Inhibitors of Angiotensin II: Potential Hazards for Patients at Risk for Anaphylaxis?
- 30 June 1997
- journal article
- editorial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 78 (6) , 527-529
- https://doi.org/10.1016/s1081-1206(10)63212-7
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Angiotensin in Human Leukocytes of Patients with Insect Venom Anaphylaxis and Healthy VolunteersInternational Archives of Allergy and Immunology, 1995
- Angiotensinamide in the treatment of probable anaphylaxis to succinylated gelatin (Gelofusine)Anaesthesia, 1994
- Histamine, Tryptase, Norepinephrine, Angiotensinogen, Angiotensin-Converting Enzyme, Angiotensin I and II in Plasma of Patients with Hymenoptera Venom AnaphylaxisInternational Archives of Allergy and Immunology, 1994
- Increased Urinary Excretion of Angiotensin during Anaphylactoid ReactionsInternational Archives of Allergy and Immunology, 1994
- Urinary excretion of angiotensin I, II, arginine vasopressin and oxytocin in patients with anaphylactoid reactionsClinical and Experimental Allergy, 1992
- Angio-oedema in relation to treatment with angiotensin converting enzyme inhibitors.BMJ, 1992
- Anaphylactic Shock: Pathophysiology and Implications for TreatmentPublished by Springer Nature ,1989
- Clinical Observations on the Pathophysiology and Treatment of Anaphylactic Cardiovascular CollapseAnaesthesia and Intensive Care, 1986
- Hemodynamics, Plasma Histamine, and Catecholamine Concentrations during an Anaphylactoid Reaction to MorphineAnesthesiology, 1981
- Anaphylactic shock in man. Report of two cases with detailed hemodynamic and metabolic studiesArchives of internal medicine (1960), 1967